← Evidence map

ArticleSkin health and disease2023

CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T-cell lymphomas.

Jun Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37275413